DISCOVER
Each product in the Greenbiom® line is formulated from natural extracts of mushrooms, obtained through a unique extraction method developed by the research team. This innovative extraction method preserves all the active substances and beneficial properties of the ingredients, thus ensuring maximum effectiveness in their final concentrated form.
What gives it uniqueness and innovative character?
At Greenbiom®, we are dedicated to deeply understanding the colon microbiota and its impact on overall health.
First of all, our own, innovative extraction method, developed by our research team, which ensures the preservation of active substances and implicitly the benefits of natural ingredients, but also the unique formula of "metabiotic" products (latest generation probiotics), with years of research behind it.
R&D
The benefits of using boletus extract, supported by scientific research
Boletus edulis extract
A New Modulator of Dysbiotic Microbiota
Regular antibiotic administration is a public problem due to the prejudices of large population groups and the high frequency with which antimicrobial products are prescribed. The current study aimed to evaluate the in vitro effect of a novel extract from Boletus edulis (BEE) on the human microbiota.
One of the disadvantages of this extensive use is the disruption of the human microbiota, leading to potential negative health consequences. In vitro evaluation of BEE consisted of determining its cytotoxicity, the influence on the concentration of four types of cytokines (IL-6, IL-10, IL-1β, TNFα) and the ability to modulate the human microbiota after antibiotic administration. The latter was assessed by microbiome analysis and evaluation of the synthesis of short-chain fatty acids (SCFAs). At the same time, the total polyphenol content, antioxidant capacity and compositional analysis of the extract (individual polyphenol composition) were determined.
The results showed that BEE modulates the microbial pattern and reduces inflammatory progression. The data demonstrated antioxidant properties correlated with increased synthesis of biomarkers, such as SCFAs, which attenuated antibiotic-induced dysbiosis without the use of probiotic products.